Skip to content
ASEAN Network for Research, Diagnostics and Vaccines Innovation

ASEAN Network for Research, Diagnostics and Vaccines Innovation

RUO lab reagent, FBS, Normal human Cell culture bovine serum

  • Home
  • hematopoietic stem cell transplantation
  • cytotoxic T lymphocyte antigen-4
  • acute graft-versus-host disease
  • cDNA expression library
  • nicking enzyme
  • ligation-independent cloning
  • Contact Us

Identification of Avramr1 from Phytophthorainfestans utilizing lengthy learn and cDNA pathogen-enrichment

November 6, 2020
 |  No Comments
asean-ndi

Identification of Avramr1 from Phytophthorainfestans utilizing lengthy learn and cDNA pathogen-enrichment sequencing (PenSeq)

 

Potato late blight, brought on by the oomycete pathogen Phytophthorainfestans, considerably hampers potato manufacturing. Lately, a brand new Resistance to Phytophthorainfestans (Rpi) gene, Rpi-amr1, was cloned from a wild Solanum species, Solanumamericanum.

 

Identification of the corresponding acknowledged effector (Avirulence or Avr) genes from P. infestans is essential to elucidating their naturally occurring sequence variation, which in flip informs the potential sturdiness of the cognate late blight resistance. To establish the P. infestans effector acknowledged by Rpi-amr1, we screened obtainable RXLR effector libraries and used lengthy learn and cDNA pathogen-enrichment sequencing (PenSeq) on 4 P. infestans isolates to discover the untested effectors.

 

Utilizing single-molecule real-time sequencing (SMRT) and cDNA PenSeq, we recognized 47 extremely expressed effectors from P. infestans, together with PITG_07569, which triggers a extremely particular cell loss of life response when transiently coexpressed with Rpi-amr1 in Nicotianabenthamiana, suggesting that PITG_07569 is Avramr1. Right here we display that lengthy learn and cDNA PenSeq allows the identification of full-length RXLR effector households and their expression profile. This examine has revealed key insights into the evolution and polymorphism of a fancy RXLR effector household that’s related to the popularity by Rpi-amr1.

asean-ndi

asean-ndi

 

VEGF E (Orf Virus)

cyt-263 ProSpec Tany 2µg
EUR 60
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

Orf Virus VEGF-E, Heparin-binding

MBS691480-002mg MyBiosource 0.02mg
EUR 440

Orf Virus VEGF-E, Heparin-binding

MBS691480-5x002mg MyBiosource 5x0.02mg
EUR 1685

Orf Virus VEGF-E, Heparin-binding

MBS691994-0005mg MyBiosource 0.005mg
EUR 300

Orf Virus VEGF-E, Heparin-binding

MBS691994-5x0005mg MyBiosource 5x0.005mg
EUR 1050

Orf virus VEGF-E Recombinant Protein

300-044 ReliaTech 5 µg
EUR 136.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein

300-044S ReliaTech 2 µg
EUR 73.5
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein

300-045 ReliaTech 20 µg
EUR 357
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Anti-Orf Virus VEGF-E Antibody

102-PA70 ReliaTech 50 µg
EUR 115.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg

QP10912-1mg EnQuireBio 1mg
EUR 6181.2

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug

QP10912-2ug EnQuireBio 2ug
EUR 186

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug

QP10912-10ug EnQuireBio 10ug
EUR 241.2

Orf virus VEGF-E, Heparin-binding Recombinant Protein

300-046 ReliaTech 20 µg
EUR 194.25
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

Orf virus VEGF-E, Heparin-binding Recombinant Protein

300-046S ReliaTech 5 µg
EUR 94.5
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus)

PROTQ2F842 BosterBio Regular: 10ug
EUR 250
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa.

ov-VEGF-E (Orf virus) (Recombinant) Human

GWB-C8AD60 GenWay Biotech 0.005 mg Ask for price

VEGFE protein (Orf virus)

30R-AV011 Fitzgerald 5 ug
EUR 381
Description: Purified recombinant VEGFE protein (Orf virus)

VEGFE protein (Orf virus)

MBS538323-0005mg MyBiosource 0.005mg
EUR 505

VEGFE protein (Orf virus)

MBS538323-5x0005mg MyBiosource 5x0.005mg
EUR 2125

Recombinant Orf Virus VEGFE Protein

VAng-Lsx0417-inquire Creative Biolabs inquire Ask for price
Description: Orf Virus VEGFE, recombinant protein from Baculovirus.

Recombinant Orf Virus VEGFE Protein [His]

VAng-Lsx0418-inquire Creative Biolabs inquire Ask for price
Description: Orf Virus VEGFE [His], recombinant protein from E. coli.

Cytochalasin E

C197-1MG TOKU-E 1 mg
EUR 79.77
Description: 36011-19-5

Cytochalasin E

C197-5MG TOKU-E 5 mg
EUR 276.58
Description: 36011-19-5

Chevalone E

C257-0.5MG TOKU-E 0.5 mg
EUR 153.46
Description: 1315451-94-5

Chevalone E

C257-2.5MG TOKU-E 2.5 mg
EUR 536.69
Description: 1315451-94-5

Berkeleylactone E

B087-1MG TOKU-E 1 mg
EUR 145.66
Description: 122211-62-5

Berkeleylactone E

B087-5MG TOKU-E 5 mg
EUR 509.81
Description: 122211-62-5

Deoxybrevianamide E

D083-1MG TOKU-E 1 mg
EUR 191.61
Description: 34610-68-9

Deoxybrevianamide E

D083-5MG TOKU-E 5 mg
EUR 670.21
Description: 34610-68-9

Oligomycin E

O021-1MG TOKU-E 1 mg
EUR 212.42
Description: 110231-34-0

Oligomycin E

O021-5MG TOKU-E 5 mg
EUR 741.31
Description: 110231-34-0

Paraherquamide E

P070-0.5MG TOKU-E 0.5 mg
EUR 271.38
Description: 125600-53-5

Paraherquamide E

P070-2.5MG TOKU-E 2.5 mg
EUR 947.66
Description: 125600-53-5

Phenelfamycin E

P078-1MG TOKU-E 1 mg
EUR 212.42
Description: 114451-31-9

Phenelfamycin E

P078-5MG TOKU-E 5 mg
EUR 741.31
Description: 114451-31-9

Roquefortine E

R035-1MG TOKU-E 1 mg
EUR 150
Description: 871982-52-4

Roquefortine E

R035-5MG TOKU-E 5 mg
EUR 524.55
Description: 871982-52-4

Azithromycin impurity E EvoPure®

A074-5MG TOKU-E 5 mg
EUR 605.18
Description: 612069-27-9

Hepatitis E virus ORF 3 Recombinant Protein

53-335 ProSci 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 3 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein

53-336 ProSci 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein

53-337 ProSci 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

abx263083-10mg Abbexa 10 mg
EUR 325

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

20-abx263083 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 2 µg
  • 10 ug
  • 1 mg

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

abx263083-25mg Abbexa 25 mg
EUR 6500

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

abx263083-5mg Abbexa 5 mg
EUR 225

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)

MBS1007472-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 990

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)

MBS1007472-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 555

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)

MBS1007472-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 745

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)

MBS1007472-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 660

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)

MBS1007472-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 870

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

7-01759 CHI Scientific 2µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

7-01760 CHI Scientific 10µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

7-01761 CHI Scientific 1mg Ask for price

Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant)

22060748-1 Bio-WORLD 2 µg
EUR 190.94

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

cyt-263-10g ProSpec Tany 10µg
EUR 145

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

cyt-263-1mg ProSpec Tany 1mg
EUR 5100

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

cyt-263-2g ProSpec Tany 2µg
EUR 60

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

MBS142140-0002mg MyBiosource 0.002mg
EUR 240

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

MBS142140-001mg MyBiosource 0.01mg
EUR 310

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

MBS142140-1mg MyBiosource 1mg
EUR 5325

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

MBS142140-5x1mg MyBiosource 5x1mg
EUR 23640

Vascular Endothelial Growth Factor-E Recombinant (Orf Virus)

rAP-2496 Angio Proteomie Inquiry Ask for price

Hepatitis E Virus ORF3 Protein

20-abx260138 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF3 Protein

abx260138-20g Abbexa 20 µg
EUR 950

Hepatitis E Virus ORF3 Protein

abx260138-5g Abbexa 5 µg
EUR 350

Hepatitis E virus

8942 Virostat 100 ug
EUR 340
Description: ORF 2

Hepatitis E virus

8943 Virostat 100 ug
EUR 340
Description: ORF 2

Hepatitis E virus

8944 Virostat 100 ug
EUR 340
Description: ORF 3

Hepatitis E virus

MBS328020-01mg MyBiosource 0.1mg
EUR 435

Hepatitis E virus

MBS328020-5x01mg MyBiosource 5x0.1mg
EUR 1865

Hepatitis E virus

MBS328021-01mg MyBiosource 0.1mg
EUR 435

Hepatitis E virus

MBS328021-5x01mg MyBiosource 5x0.1mg
EUR 1865

Hepatitis E virus

MBS328022-01mg MyBiosource 0.1mg
EUR 435

Hepatitis E virus

MBS328022-5x01mg MyBiosource 5x0.1mg
EUR 1865

Hepatitis E virus

PCR-H498-PCRH49848R Bioingentech PCR-H498-48R
EUR 485

Hepatitis E virus

PCR-H498-PCRH49896R Bioingentech PCR-H498-96R
EUR 685

Hepatitis E virus

Oneq-H498-OneqH498100R Bioingentech Oneq-H498-100R
EUR 1028

Hepatitis E virus

Oneq-H498-OneqH498150R Bioingentech Oneq-H498-150R
EUR 1438

Hepatitis E virus

Oneq-H498-OneqH49850R Bioingentech Oneq-H498-50R
EUR 728

Recombinant Hepatitis E Virus ORF3 

7-07450 CHI Scientific 100µg Ask for price

Recombinant Hepatitis E Virus ORF3 

7-07451 CHI Scientific 500µg Ask for price

Recombinant Hepatitis E Virus ORF3 

7-07452 CHI Scientific 1000µg Ask for price

Hepatitis E Virus ORF3 (Recombinant)

22060181-1 Bio-WORLD 100 µg
EUR 344.89

Recombinant Hepatitis E Virus ORF3 

MBS142588-01mg MyBiosource 0.1mg
EUR 330

Recombinant Hepatitis E Virus ORF3 

MBS142588-05mg MyBiosource 0.5mg
EUR 825

Recombinant Hepatitis E Virus ORF3 

MBS142588-1mg MyBiosource 1mg
EUR 1515

Recombinant Hepatitis E Virus ORF3 

MBS142588-5x1mg MyBiosource 5x1mg
EUR 6485

Hepatitis E Virus ORF3 Recombinant

rAP-5321 Angio Proteomie Inquiry Ask for price

Hepatitis E Virus, ORF2, Recombinant (HEV)

MBS637880-01mg MyBiosource 0.1mg
EUR 455

Hepatitis E Virus, ORF2, Recombinant (HEV)

MBS637880-05mg MyBiosource 0.5mg
EUR 1025

Hepatitis E Virus, ORF2, Recombinant (HEV)

MBS637880-5x05mg MyBiosource 5x0.5mg
EUR 4470

Hepatitis E Virus, ORF3, Recombinant (HEV)

MBS636730-01mg MyBiosource 0.1mg
EUR 735

Hepatitis E Virus, ORF3, Recombinant (HEV)

MBS636730-5x01mg MyBiosource 5x0.1mg
EUR 3155

VEGF (165): Human Recombinant E Coli

GWB-BDEFEF GenWay Biotech 1 mg Ask for price

OPPA00528-2UG - VEGF E Protein

OPPA00528-2UG Aviva Systems Biology 2ug
EUR 70

Hepatitis E Virus ORF2 (452-617) Protein

20-abx260268 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF2 (452-617) Protein

abx260268-20g Abbexa 20 µg
EUR 950

Hepatitis E Virus ORF2 (452-617) Protein

abx260268-5g Abbexa 5 µg
EUR 350

Hepatitis E Virus ORF2 (633-659) Protein

20-abx260269 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF2 (633-659) Protein

abx260269-25g Abbexa 25 µg
EUR 950

Hepatitis E Virus ORF2 (633-659) Protein

abx260269-5g Abbexa 5 µg
EUR 350

Hepatitis E Virus ORF2 (403-461) Protein

20-abx260270 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF2 (403-461) Protein

abx260270-25g Abbexa 25 µg
EUR 950

Hepatitis E Virus ORF2 (403-461) Protein

abx260270-5g Abbexa 5 µg
EUR 350

Hepatitis E virus (ratHEV)

PCR-V372-PCRV37248R Bioingentech PCR-V372-48R
EUR 485

Hepatitis E virus (ratHEV)

PCR-V372-PCRV37296R Bioingentech PCR-V372-96R
EUR 685

Hepatitis E virus (ratHEV)

Oneq-V372-OneqV372100R Bioingentech Oneq-V372-100R
EUR 1028

Hepatitis E virus (ratHEV)

Oneq-V372-OneqV372150R Bioingentech Oneq-V372-150R
EUR 1438

Hepatitis E virus (ratHEV)

Oneq-V372-OneqV37250R Bioingentech Oneq-V372-50R
EUR 728

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)

MBS1215198-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 995

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)

MBS1215198-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 560

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)

MBS1215198-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 750

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)

MBS1215198-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 670

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)

MBS1215198-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 875

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)

MBS1205850-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1005

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)

MBS1205850-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 570

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)

MBS1205850-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 755

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)

MBS1205850-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 680

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)

MBS1205850-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 885

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)

MBS1182981-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 990

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)

MBS1182981-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 555

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)

MBS1182981-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 745

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)

MBS1182981-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 660

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)

MBS1182981-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 870

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)

MBS1177237-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1015

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)

MBS1177237-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 585

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)

MBS1177237-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 770

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)

MBS1177237-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 700

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)

MBS1177237-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 900

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)

MBS1122067-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 990

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)

MBS1122067-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 555

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)

MBS1122067-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 745

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)

MBS1122067-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 660

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)

MBS1122067-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 870

Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E)

MBS1252431-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 995
×

 

Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31: cDNA cloning, expression and initial characterization of morphine metabolism

 

Goal: Uridine diphospho-glucuronosyltransferases (UGTs) are membrane-bound enzymes that catalyze the conjugation of glucuronic acid onto a various set of xenobiotics. Horses effectively and extensively glucuronidate a lot of xenobiotics, together with opioids, making UGTs an vital group of drug-metabolizing enzymes for the clearance of medication. Recombinant enzymes have allowed researchers to characterize the metabolism of a wide range of medication. The first goal was to clone, specific and characterize equine UGTs utilizing medication characterised as UGT substrates in different species. A secondary goal was to characterize the in vitro metabolism of morphine in horses.

 

Examine design: In vitro drug metabolism examine utilizing liver microsomes and recombinant enzyme methods.

 

Animals: Liver microsomes and RNA from tissue collected from two Thoroughbred mares euthanized for different causes.

 

Strategies: Primarily based on homology to the human UGT2B7, 4 equine UGT variants have been expressed: UGT1A1, UGT2A1, UGT2B31 and UGT2B4. cDNA sequences have been cloned and ensuing protein expressed in a baculovirus expression system. Performance of the enzymes was assessed utilizing 4-methylumbelliferone, testosterone, diclofenac and ketoprofen. Recombinant enzyme, management cells, equine liver microsomes and human UGT2B7 supersomes have been then incubated with morphine. Concentrations of metabolites have been measured utilizing liquid chromatography-tandem mass spectrometry and enzyme kinetics decided.

 

Outcomes: 4-Methylumbelliferone was glucuronidated by all expressed equine UGTs. Testosterone glucuronide was not produced by any of the expressed enzymes, and diclofenac glucuronide and ketoprofen glucuronide have been produced by UG2A1 and UGT1A1, respectively. UGT2B31 metabolized morphine to morphine-3-glucuronide and low concentrations of morphine-6-glucuronide.

 

Conclusions and scientific relevance: That is the primary profitable expression of useful recombinant equine UGTs. UGT2B31 contributes to the glucuronidation of morphine; nonetheless, it’s in all probability not the primary metabolizing enzyme. These outcomes warrant additional investigation of equine UGTs, together with expression of further enzymes and additional characterization of UGT2B31 as a contributor to morphine metabolism.

 

An progressive genosensor for the monitoring of Leishmaniaspp sequence utilizing binding of pDNA to cDNA primarily based on Cit-AgNPs

 

Leishmaniasis thought of as essentially the most essential epidemic-prone illnesses based on the World Well being Group. Early diagnoses and remedy of Leishmania an infection is a good problem since, it has no symptom and is resistance to medication. Subsequently, there’s an pressing want for delicate and exact detection of this pathogen.

 

On this examine, a brand new technique was developed for optical biosensing of Leishmaniaspp sequence primarily based on hybridization of Citrate capped Ag nanoparticles bonded to particular single stranded DNA probe of Leishmania spp. Aggregation of the Citrate capped Ag nanoparticles within the existence or lack of a cDNA sequence of Leishmania, trigger eye catching and appreciable vital alter within the UV-vis.

 

The obtained low restrict of quantification (LLOQ) of was achieved as 1ZM. Primarily based on experimental ends in optimum situations, fast bioanalysis of Leishmaniaspp sequence was carried out (2 min). So, this probe can be utilized for the scientific analysis of this pathogen and an infection illness.

 

RNA-cDNA hybrids mediate transposition via different mechanisms

Retrotransposons can represent half of eukaryotic genomes. Retrotransposon dysregulation destabilizes genomes and has been linked to various human diseases. Emerging regulators of retromobility include RNA-DNA hybrid-containing structures known as R-loops. Accumulation of these structures at the transposons of yeast 1 (Ty1) elements has been shown to increase Ty1 retromobility through an unknown mechanism. Here, via a targeted genetic screen, we identified the rnh1Δ rad27Δ yeast mutant, which lacked both the Ty1 inhibitor Rad27 and the RNA-DNA hybrid suppressor Rnh1. The mutant exhibited elevated levels of Ty1 cDNA-associated RNA-DNA hybrids that promoted Ty1 mobility. Moreover, in this rnh1Δ rad27Δ mutant, but not in the double RNase H mutant rnh1Δ rnh201Δ, RNA-DNA hybrids preferentially existed as duplex nucleic acid structures and increased Ty1 mobility in a Rad52-dependent manner.
Know More-  IIT jee coaching in Dehradun
The data indicate that in cells lacking RNA-DNA hybrid and Ty1 repressors, elevated levels of RNA-cDNA hybrids, which are associated with duplex nucleic acid structures, boost Ty1 mobility via a Rad52-dependent mechanism. In contrast, in cells lacking RNA-DNA hybrid repressors alone, elevated levels of RNA-cDNA hybrids, which are associated with triplex nucleic acid structures, boost Ty1 mobility via a Rad52-independent process. We propose that duplex and triplex RNA-DNA hybrids promote transposon mobility via Rad52-dependent or -independent mechanisms.

Identification of salinity responsive genes in lavender through cDNA-AFLP

Currently, a global demand exists forlavender as a significant medicinal plant and source of essential oils. Freshwater and arable lands are two major factors that inhibit extensive farming of medicinal plants in Iran. Saline water from seas and salty soil may be new resources for agricultural use, especially for medicinal plants.
We sought to extend our knowledge of the Lavandula angustifolia genome and molecular basis of its salinity tolerance by using cDNA amplified fragment length polymorphism (cDNA-AFLP) to investigate the changes in plant transcriptomes in response to NaCl.
All identified transcript derived fragments (TDF) were assigned as novel L. angustifolia genes related to signal transduction, regulation of gene expression, alternative splicing, autophagy, and secondary metabolite biosynthesis. qRT-PCR analysis of the TDFs in response to different concentrations of NaCl revealed various levels of mRNA of the identified genes in this plant. Our findings provided primary insights into the molecular response of L. angustifolia to salinity.

VEGFE protein (Orf virus)

MBS538323-5x0005mg MyBiosource 5x0.005mg
EUR 2125

Recombinant Orf Virus VEGFE Protein

VAng-Lsx0417-inquire Creative Biolabs inquire Ask for price
Description: Orf Virus VEGFE, recombinant protein from Baculovirus.

Recombinant Orf Virus VEGFE Protein [His]

VAng-Lsx0418-inquire Creative Biolabs inquire Ask for price
Description: Orf Virus VEGFE [His], recombinant protein from E. coli.

Orf virus VEGF-E Recombinant Protein

300-044 ReliaTech 5 µg
EUR 136.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein

300-044S ReliaTech 2 µg
EUR 73.5
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein

300-045 ReliaTech 20 µg
EUR 357
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E, Heparin-binding Recombinant Protein

300-046 ReliaTech 20 µg
EUR 194.25
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

Orf virus VEGF-E, Heparin-binding Recombinant Protein

300-046S ReliaTech 5 µg
EUR 94.5
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

Orf Virus VEGF-E

MBS691797-002mg MyBiosource 0.02mg
EUR 695

Orf Virus VEGF-E

MBS691797-5x002mg MyBiosource 5x0.02mg
EUR 2830

Orf Virus VEGF-E

MBS691891-0005mg MyBiosource 0.005mg
EUR 350

Orf Virus VEGF-E

MBS691891-5x0005mg MyBiosource 5x0.005mg
EUR 1275

Orf Virus VEGF-E

MBS691947-0002mg MyBiosource 0.002mg
EUR 265

Orf Virus VEGF-E

MBS691947-5x0002mg MyBiosource 5x0.002mg
EUR 890

VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus)

PROTQ2F842 BosterBio Regular: 10ug
EUR 250
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa.

Orf Virus VEGF-E, Heparin-binding

MBS691480-002mg MyBiosource 0.02mg
EUR 440

Orf Virus VEGF-E, Heparin-binding

MBS691480-5x002mg MyBiosource 5x0.02mg
EUR 1685

Orf Virus VEGF-E, Heparin-binding

MBS691994-0005mg MyBiosource 0.005mg
EUR 300

Orf Virus VEGF-E, Heparin-binding

MBS691994-5x0005mg MyBiosource 5x0.005mg
EUR 1050

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg

QP10912-1mg EnQuireBio 1mg
EUR 6181.2

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug

QP10912-2ug EnQuireBio 2ug
EUR 186

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug

QP10912-10ug EnQuireBio 10ug
EUR 241.2

Anti-Orf Virus VEGF-E Antibody

102-PA70 ReliaTech 50 µg
EUR 115.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Human PDGFC / VEGFE, Fc Tag

E24PHA208 EnoGene 50 μg
EUR 180

Human PDGFC / VEGFE, His Tag

E24PHA209 EnoGene 50 μg
EUR 225

VEGF E (Orf Virus)

cyt-263 ProSpec Tany 2µg
EUR 60
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

Cynomolgus / Rhesus Macaque PDGFC / VEGFE, Fc Tag

E24PCA081 EnoGene 50 μg
EUR 180

Cynomolgus / Rhesus Macaque PDGFC / VEGFE, His Tag

E24PCA082 EnoGene 50 μg
EUR 225

Recombinant Orf virus 10 kDa fusion protein

MBS1129089-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1015

Recombinant Orf virus 10 kDa fusion protein

MBS1129089-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 580

Recombinant Orf virus 10 kDa fusion protein

MBS1129089-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 765

Recombinant Orf virus 10 kDa fusion protein

MBS1129089-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 695

Recombinant Orf virus 10 kDa fusion protein

MBS1129089-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 895

Recombinant Orf virus Protein F9 homolog (A3R)

MBS1202811-INQUIRE MyBiosource INQUIRE Ask for price

Recombinant Orf virus Protein F9 homolog (A3R)

MBS1072246-INQUIRE MyBiosource INQUIRE Ask for price

Recombinant Orf virus Protein F9 homolog (A3R)

MBS7038987-002mg MyBiosource 0.02mg
EUR 1335

Recombinant Orf virus Protein F9 homolog (A3R)

MBS7038987-01mg MyBiosource 0.1mg
EUR 2300

Recombinant Orf virus Protein F9 homolog (A3R)

MBS7038987-5x01mg MyBiosource 5x0.1mg
EUR 10300

Recombinant Orf virus Protein F9 homolog (A3R)

MBS7038988-002mg MyBiosource 0.02mg
EUR 1330

Recombinant Orf virus Protein F9 homolog (A3R)

MBS7038988-01mg MyBiosource 0.1mg
EUR 2295

Recombinant Orf virus Protein F9 homolog (A3R)

MBS7038988-5x01mg MyBiosource 5x0.1mg
EUR 10295

Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics anti-PDGF-C)

E24CHA317 EnoGene 100 μg
EUR 225
Description: Available in various conjugation types.

Hepatitis E virus ORF 3 Recombinant Protein

53-335 ProSci 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 3 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein

53-336 ProSci 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein

53-337 ProSci 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Recombinant Orf virus Protein F9 homolog (A3R), partial

MBS7061474-INQUIRE MyBiosource INQUIRE Ask for price

Recombinant Orf virus Protein F9 homolog (A3R), partial

MBS7061495-INQUIRE MyBiosource INQUIRE Ask for price

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

abx263083-10mg Abbexa 10 mg
EUR 325

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

20-abx263083 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 2 µg
  • 10 ug
  • 1 mg

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

abx263083-25mg Abbexa 25 mg
EUR 6500

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

abx263083-5mg Abbexa 5 mg
EUR 225

Recombinant Figwort mosaic virus Movement protein (ORF I)

MBS1050972-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1200

Recombinant Figwort mosaic virus Movement protein (ORF I)

MBS1050972-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 850

Recombinant Figwort mosaic virus Movement protein (ORF I)

MBS1050972-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 990

Recombinant Figwort mosaic virus Movement protein (ORF I)

MBS1050972-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1020

Recombinant Figwort mosaic virus Movement protein (ORF I)

MBS1050972-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1235484-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1235484-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1235484-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1235484-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1235484-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1131598-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1131598-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1131598-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1131598-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1131598-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1250494-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1250494-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1250494-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1115

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1250494-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1250494-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1007636-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1007636-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1007636-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1007636-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1007636-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1092759-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1092759-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1092759-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1092759-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)

MBS1092759-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1310

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)

MBS1432961-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1045

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)

MBS1432961-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 620

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)

MBS1432961-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 795

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)

MBS1432961-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 720

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)

MBS1432961-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 930

Virus Measles Virus (MeV) Protein

abx670263-1ml Abbexa 1 ml
EUR 543.6

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1184457-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1205

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1184457-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 855

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1184457-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 995

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1184457-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1030

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1184457-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1130

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1033786-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1205

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1033786-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 855

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1033786-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 995

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1033786-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1030

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1033786-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1130

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1093694-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1205

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1093694-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 855

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1093694-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 995

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1093694-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1030

Recombinant Cauliflower mosaic virus Movement protein (ORF I)

MBS1093694-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1130

Recombinant Walleye dermal sarcoma virus ORF-B protein

MBS7041397-002mg MyBiosource 0.02mg
EUR 1615

Recombinant Walleye dermal sarcoma virus ORF-B protein

MBS7041397-01mg MyBiosource 0.1mg
EUR 2570

Recombinant Walleye dermal sarcoma virus ORF-B protein

MBS7041397-5x01mg MyBiosource 5x0.1mg
EUR 11530

Virus West Nile Virus (WNV) Protein

abx670276-100ug Abbexa 100 ug
EUR 794.4

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)

MBS1130671-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1355

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)

MBS1130671-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 1055

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)

MBS1130671-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 1125

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)

MBS1130671-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1230

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)

MBS1130671-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1310

Recombinant Carnation etched ring virus Movement protein (ORF I)

MBS1056689-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1195

Recombinant Carnation etched ring virus Movement protein (ORF I)

MBS1056689-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 845

Recombinant Carnation etched ring virus Movement protein (ORF I)

MBS1056689-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 985

Recombinant Carnation etched ring virus Movement protein (ORF I)

MBS1056689-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 1015

Recombinant Carnation etched ring virus Movement protein (ORF I)

MBS1056689-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 1125

Virus Hepatitis A Virus (HAV) Protein

abx670259-1ml Abbexa 1 ml
EUR 427.2

Virus Yellow Fever Virus (YFV) Protein

abx670277-100ug Abbexa 100 ug
EUR 644.4

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)

MBS1213579-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1040

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)

MBS1213579-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 615

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)

MBS1213579-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 790

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)

MBS1213579-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 715

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)

MBS1213579-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 925

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)

MBS1057844-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1085

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)

MBS1057844-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 675

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)

MBS1057844-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 840

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)

MBS1057844-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 785

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)

MBS1057844-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 980

Virus Varicella Zoster Virus (VZV) Protein

abx670269-1ml Abbexa 1 ml
EUR 794.4

Hepatitis E Virus ORF3 Protein

20-abx260138 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF3 Protein

abx260138-20g Abbexa 20 µg
EUR 950

Hepatitis E Virus ORF3 Protein

abx260138-5g Abbexa 5 µg
EUR 350

Recombinant Walleye dermal sarcoma virus ORF-B protein, partial

MBS7091428-INQUIRE MyBiosource INQUIRE Ask for price

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1149572-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1149572-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1149572-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1149572-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1149572-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 940

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1261084-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1261084-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1261084-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1261084-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1261084-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 940

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1053151-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1053151-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1053151-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1053151-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1053151-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 940

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1013968-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1013968-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1013968-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1013968-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)

MBS1013968-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 940

Virus Respiratory Syncytial Virus (RSV) Protein

abx670078-01mg Abbexa 0.1 mg
EUR 594

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1125301-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1125301-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1125301-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1125301-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1125301-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1236167-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1236167-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1236167-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1236167-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1236167-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1208165-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1020

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1208165-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 595

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1208165-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 775

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1208165-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 690

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1208165-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 910

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1161869-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1161869-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1161869-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1161869-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1161869-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1255499-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1255499-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1255499-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1255499-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1255499-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1029118-002mgBaculovirus MyBiosource 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1029118-002mgEColi MyBiosource 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1029118-002mgYeast MyBiosource 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1029118-01mgEColi MyBiosource 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)

MBS1029118-01mgYeast MyBiosource 0.1mg(Yeast)
EUR 975

Varicella Zoster Virus ORF26 Protein

20-abx260176 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Varicella Zoster Virus ORF26 Protein

abx260176-20g Abbexa 20 µg
EUR 950
×
Tags: genome annotation, genome bins, genome biology, genome browser, genome browser ucsc, genome definition, genome editing, genome genpact login, genome in a sentence, genome link, genome medical, genome of saccharomyces cerevisiae, genome project, genome research, genome sequence, genome sequencing, genome sequencing machine, genome testing, genome-wide association studies, genomeme, genomes meaning

Post navigation

← Identification of salinity responsive genes in lavender by way of cDNA-AFLP
In-Yeast Meeting of Coronavirus Infectious cDNA Clones →

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Translating Research to Practice: The Impact of Glycoproteomics in Next-Generation Drug Development
  • Glycosylation and Its Influence on mAbs: Improving Therapeutic Potential Through Glycoengineering
  • Uncovering the Mechanisms of Glycan Biosynthesis: Transforming Cancer Diagnostics Through Advanced Glycoproteomics
  • The Rise of Glycobiology: Advancing Tailored Therapies Through Glycan Profiling and Profiling
  • Glycan-Based Therapeutics: Examining the Potential of Glycan Research in Contemporary Healthcare

Categories

  • acute graft-versus-host disease
  • cDNA expression library
  • cytotoxic T lymphocyte antigen-4
  • genome
  • grapevine
  • hematopoietic stem cell transplantation
  • infectious cDNA clone
  • ligation-independent cloning
  • nicking enzyme
  • pathogenicity
  • piglets
  • porcine deltacoronavirus
  • Uncategorized
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    

Pages

  • Contact Us
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    

Tags

cdna.tv cdna2 cdna amd cdna application cdna avm cdnacp cdnaf cdna for qpcr cdna library cdname cdnap cdna sbs cdna sequence cdna sequencing cdna stock cdna stock price cdna synthesis cdna synthesis pcr cdna synthesis protocol cdnaturally cdna vs genomic cdna vs genomic dna dna.hrblock.com dna bts dna definition dna extraction dna gacha life dnalion7 youtube dna lyrics dna painter dna polymerase dna productions dna replication dna synthesis dna testing protein atlas protein balls protein function protein in eggs protein in urine meaning protein monomer protein rich foods protein shake recipes protein shakes for weight loss protein supplements
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    
Categories
  • acute graft-versus-host disease
  • cDNA expression library
  • cytotoxic T lymphocyte antigen-4
  • genome
  • grapevine
  • hematopoietic stem cell transplantation
  • infectious cDNA clone
  • ligation-independent cloning
  • nicking enzyme
  • pathogenicity
  • piglets
  • porcine deltacoronavirus
  • Uncategorized
Quick Links
  • Contact Us
Recent Posts
  • Translating Research to Practice: The Impact of Glycoproteomics in Next-Generation Drug Development
  • Glycosylation and Its Influence on mAbs: Improving Therapeutic Potential Through Glycoengineering
  • Uncovering the Mechanisms of Glycan Biosynthesis: Transforming Cancer Diagnostics Through Advanced Glycoproteomics
  • The Rise of Glycobiology: Advancing Tailored Therapies Through Glycan Profiling and Profiling
  • Glycan-Based Therapeutics: Examining the Potential of Glycan Research in Contemporary Healthcare
SKT Software